Robert Julian, DDS
Oral & Maxillofacial Surgery · Fresno, CANPI 1427119791
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Synthes GmbH at 31.1% of the total. Reporting peaked in 2019 at $4,385 and has fallen 88.6% since, to $498 in 2025. Among oral & maxillofacial surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $80.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$4K
- Zimmer Biomet$3K
- Inspire Medical Systems, Inc.$990
- Johnson & Johnson$936
- Kls-martin L.p.$719
- Axogen$452
- plus $1K from 18 others
What the payments were for
- Consulting fees$1,50513%
- Speaking & faculty fees$2,50022%
- Travel & lodging$2,30820%
- Food & beverage$4,99143%
- Education$1942%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 5 | $3,574 |
| Zimmer Biomet | 17 | $3,378 |
| Inspire Medical Systems, Inc. | 7 | $990 |
| Johnson & Johnson(2 entities) | 37 | $936 |
| Kls-martin L.p. | 12 | $719 |
| Axogen | 9 | $452 |
| Stryker | 7 | $227 |
| Astellas Pharma US Inc | 4 | $225 |
| Livanova USA, Inc. | 6 | $207 |
| Antares Pharma, Inc. | 13 | $173 |
| Dendreon Pharmaceuticals LLC | 5 | $107 |
| Bayer | 4 | $93 |
| Immunitybio, Inc. | 3 | $77 |
| Smith+Nephew | 2 | $46 |
| KARL Storz Endoscopy-america | 2 | $40 |
| Myriad Genetic Laboratories, Inc. | 2 | $35 |
| Nobel Biocare USA | 1 | $35 |
| Implant Direct Sybron International LLC | 1 | $35 |
| Blue Earth Diagnostics | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Medtronic | 1 | $24 |
| Geistlich Pharma, North America, Inc. | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,498 in reported general payments places this provider in the 90th percentile of 941 oral & maxillofacial surgery providers in California.
See all oral & maxillofacial surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 18 | $416 |
| Dexamethasone | 11 | $186 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $112 |
| Amoxicillin | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Fresno
- Allen ChienFresno$17K
- Ardavan KheradpirFresno$16K
- Thomas CurielFresno$14K
- Brian HuhFresno$12K
- Edmond BedrossianSan Francisco$3.7M
- Peter WohrleNewport Beach$735K
- Jone KimBrea$721K
- G William ArnettSanta Barbara$713K
- Arshiya SharafiSan Diego$457K
- Alan HerfordColton$292K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.